Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location | |
|---|---|---|---|---|
A Study of BION-1301 in Adults With IgA Nephropathy |
IgA Nephropathy, Immunoglobulin A Nephropathy | Phase3 | Argentina Australia Belgium Brazil Canada China Croatia Czechia France Germany Greece India Israel Italy Japan Korea, Republic of Malaysia Mexico Spain Taiwan Turkey United Kingdom United States View All |
NCT05852938 |
A Study to Investigate the Safety, Tolerability and Preliminary Efficacy of NGI226 Microparticles in Patients With Achilles Tendinopathy |
Achilles Tendinopathy | Phase2 | France Germany United Kingdom United States View All |
NCT05592990 |
A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration |
Age-Related Macular Degeneration | Phase2 | United Kingdom | NCT05230537 |
Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS) |
Atypical Hemolytic Uremic Syndrome | Phase3 | China Japan Turkey United Kingdom View All |
NCT05935215 |
Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors |
Neuroblastoma | Phase1, Phase2 | Australia France Germany Italy Singapore Spain United Kingdom United States View All |
NCT05429502 |
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation. |
Lymphatic Malformations | Phase2, Phase3 | Australia Belgium France Germany Italy Spain United States View All |
NCT05948943 |
A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines |
Chronic Inducible Urticaria | Phase3 | Argentina Australia Brazil Canada China Colombia France Hong Kong Hungary India Israel Italy Japan Korea, Republic of Malaysia Netherlands Portugal Singapore Slovakia Spain Thailand Turkey United States Vietnam View All |
NCT05976243 |
A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting |
Hypercholesterolemia | Germany | NCT05362903 | |
Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia |
Myeloid Leukemia, Philadelphia Positive | Phase1, Phase2 | China France Germany Greece Hungary Italy Japan Korea, Republic of Netherlands Poland Russian Federation Thailand Turkey United States View All |
NCT04925479 |
The Gilenya Pregnancy Registry |
Multiple Sclerosis | Argentina Australia Austria Belgium Brazil Canada Colombia Cyprus Czechia Denmark Finland France Germany Greece Hungary Ireland Israel Italy Lebanon Mexico Netherlands Poland Portugal Romania Russian Federation Saudi Arabia Slovakia Slovenia Spain Sweden Switzerland United Arab Emirates United Kingdom United States View All |
NCT01285479 |